SIC 8071 – Medical Laboratories
| Valuation | |
|---|---|
| Market Cap ($M) | 93.63 |
| Enterprise Value ($M) | 95.72 |
| Book Value ($M) | 16.99 |
| Book Value / Share | 0.36 |
| Price / Book | 5.51 |
| NCAV ($M) | -70.22 |
| NCAV / Share | -1.48 |
| Price / NCAV | -1.33 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.58 |
| Return on Assets (ROA) | -0.31 |
| Return on Equity (ROE) | -2.35 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.45 |
| Current Ratio | 1.54 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 70.19 |
| Assets | 157.41 |
| Liabilities | 140.41 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | AWM Investment Company, Inc. | 9.00 | ||
| 13D/A | MVM Partners, LLC | 9.94 | ||
| 13G | Exact Sciences Corp | 7.10 | ||
| 13G | Lytton Laurence W | 6.10 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 6,916 | 46,140 | 14.99 | |
| 8,745 | 73,378 | 11.92 | |
| 347 | 61,125 | 0.57 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| BGLC – BioNexus Gene Lab Corp. | CELC – Celcuity Inc. |
| EXAS – Exact Sciences Corporation | PMD – Psychemedics Corporation |
| VRDN – Viridian Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io